1h Free Analyst Time
The publisher has been monitoring the stroke therapeutics market and it is poised to grow by $1.54 bn during 2021-2025, progressing at a CAGR of 5.00% during the forecast period. The report on the stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high-risk factors for stroke and growing geriatric population.
The stroke therapeutics market analysis includes the type segment and geographic landscape.
The stroke therapeutics market is segmented as below:
By Type
- Ischemic stroke
- Hemorrhagic stroke
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the strong pipeline as one of the prime reasons driving the stroke therapeutics market growth during the next few years.
The report on stroke therapeutics market covers the following areas:
- Stroke therapeutics market sizing
- Stroke therapeutics market forecast
- Stroke therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stroke therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., and Sanofi SA. Also, the stroke therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Ischemic stroke - Market size and forecast 2020-2025
- Hemorrhagic stroke - Market size and forecast 2020-2025
- Market opportunity by Type
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Sanofi SA
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Type - Market share 2020-2025 (%)
- Comparison by Type
- Ischemic stroke - Market size and forecast 2020-2025 ($ million)
- Ischemic stroke - Year-over-year growth 2020-2025 (%)
- Hemorrhagic stroke - Market size and forecast 2020-2025 ($ million)
- Hemorrhagic stroke - Year-over-year growth 2020-2025 (%)
- Market opportunity by Type
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Amgen Inc. - Overview
- Amgen Inc. - Business segments
- Amgen Inc. - Key offerings
- Amgen Inc. - Key customers
- Amgen Inc. - Segment focus
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product and service
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Key customers
- AstraZeneca Plc - Segment focus
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Business segments
- Boehringer Ingelheim International GmbH - Key offerings
- Boehringer Ingelheim International GmbH - Key customers
- Boehringer Ingelheim International GmbH - Segment focus
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product and service
- Bristol Myers Squibb Co. - Key offerings
- Bristol Myers Squibb Co. - Key customers
- Bristol Myers Squibb Co. - Segment focus
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Key customers
- F. Hoffmann La Roche Ltd. - Segment focus
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Key customers
- Johnson and Johnson Inc. - Segment focus
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Key customers
- Merck and Co. Inc. - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key offerings
- Sanofi SA - Key customers
- Sanofi SA - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global stroke therapeutics market: Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., and Sanofi SA.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is strong pipeline.'
According to the report, one of the major drivers for this market is the high-risk factors for stroke.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Sanofi SA
